HEPION PHARMACEUTICALS INC (HEPA) Stock Analyst Ratings
NASDAQ:HEPA - Nasdaq - US4268973025 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to HEPA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 30.6. This target is 17826.19% above the current price.
HEPA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HEPA.
In the previous month the buy percentage consensus was at a similar level.
HEPA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-07 | Brookline Capital | Downgrade | Buy -> Hold |
| 2022-02-28 | Cantor Fitzgerald | Initiate | Overweight |